Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate

Clinical Rheumatology

Volumn 22, Issue 6, 2003, Pages 376-380

  Vasireddy, Sreekanth ^a   Talwalkar, Amruta ^b   Miller, Hazel ^c   Mehan, Rakesh ^d   Swinson, David R ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c WRIGHTINGTON HOSPITAL   (United Kingdom)

^d ROYAL BOLTON HOSPITAL   (United Kingdom)

Author keywords

Lower segment; Mobility; Osteoarthritis; Paget's disease; Pagetic arthropathy; Pain; Pamidronate

Indexed keywords

ALKALINE PHOSPHATASE; PAMIDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE;

AGED; ARTHROPATHY; ARTICLE; BONE PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEG; LUMBAR SPINE; MALE; OSTEOARTHRITIS; PAGET BONE DISEASE; PATIENT COMPLIANCE; PELVIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RADIOGRAPHY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WALKING; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; EPIDEMIOLOGY; HOSPITALIZATION; MIDDLE AGED; NONPARAMETRIC TEST; PAIN; PAIN ASSESSMENT; PROBABILITY; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEITIS DEFORMANS; OSTEOARTHRITIS; PAIN; PAIN MEASUREMENT; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 2342640375     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0762-x     Document Type: Article

References (13)

1. Barker DJP (1984) The epidemiology of Paget's disease of bone. Br Med Bull 40:396-400
2. Tiegs RD (1997) Paget's disease of bone: indications for treatment and goals of therapy. Clin Ther 19:1309-1329
3. Hamdy RC, Moore S, LeRoy J (1993) Clinical presentation of Paget's disease of the bone in older patients. South Med J 86:1097-1100
4. Winfield J, Stamp TC (1984) Bone and joint symptoms in Paget's disease. Ann Rheum Dis 43:769-773
5. Bombassei GJ, Yocono M, Raisz LG (1994) Effects of intravenous pamidronate therapy on Paget's disease of bone. Am J Med Sci 308:226-233
6. Wimalawansa SJ, Gunasekara RD (1993) Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Calcif Tissue Int 53:237-241
7. Gutteridge DH, Retallack RW, Ward LC et al. (1996) Clinical, biochemical, hematalogic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. Bone 19:387-394
8. Trombetti A, Arlot M, Thevenon J, Uebelhart B, Meunier PJ (1999) Effect of multiple intravenous pamidronate courses in Paget's disease of bone. Rev Rhum (Engl Ed) 66:467-476
9. Lyles KW, Lammers JE, Shipp KM et al. (1995) Functional and mobility impairments associated with Paget's disease of bone. J Am Geriatr Soc 43:502-506
10. Fitton A, McTavish D (1991) Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 41:289-318
11. Flores RH, Hochberg MC (1998) Definition and classification of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. New York, Oxford University Press, 1-12
12. Ibbertson HK, Henley JW, Fraser TR et al. (1979) Paget's disease of bone - clinical evaluation and treatment with diphosphonate. Aust NZ J Med 9:31-35
13. Kanis JA (1998) Pathophysiology and treatment of Paget's disease of bone, 2nd edn. London, Martin Dunitz, 111-113